JBC Biosymposia, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on July 20, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/30/27999    most recent
M102400200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiederschain, D.
Right arrow Articles by Yuan, Z.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiederschain, D.
Right arrow Articles by Yuan, Z.-M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print May 29, 2001
J. Biol. Chem, 10.1074/jbc.M102400200
Submitted on March 16, 2001
Revised on May 29, 2001
Accepted on May 25, 2001

Evidence for a distinct inhibitory factor in the regulation of p53 functional activity

Dmitri Wiederschain, Jijie Gu, and Zhi-Min Yuan

Cancer Cell Biology, Harvard School of Public Health, Boston, MA 02115

Corresponding Author: zyuan{at}hsph.harvard.edu

Under normal conditions, tumor suppressor protein p53 exists in the cell in its latent form and is unable to function as a transcription factor. Allosteric model of p53 regulation postulates that the extreme portion of p53 carboxyl terminus (aa 364-393) binds to the core domain of the protein, thereby abrogating specific DNA binding in that region. In this study we propose an alternative mechanism of p53 functional regulation, which involves a separate molecule acting in trans to inhibit p53 transcriptional activity. Through the use of chimeric proteins of p53, p63ƒ× and p73ƒÒ, we show that the extreme c-terminal domain of p53 exerts a powerful and specific inhibitory effect on the p73- and p63-driven expression of a reporter gene. Moreover, fusion of p53 extreme c-terminus to a completely unrelated transcriptional activator Gal4-VP16 also results in significant inhibition of transactivation activity. Since p73, p63 or Gal4-VP16 can not associate with any part of the p53 molecule, we conclude that p53(aa 364-393) represses transcriptional activity of chimeric proteins and p53 itself through the binding of external negative modulator(s) in that region, and not by the allosteric mechanism of regulation. In accordance with the ¡§distinct inhibitor¡¨ hypothesis, activity of wild type p53 is substantially increased by overexpression of chimeric proteins bearing p53(aa364-393), which might be due to the competitive removal of transcriptional inhibitor(s). Our findings provide basis for the identification of such negative modulators of p53 transcriptional activity.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Tang and C. Eng
PTEN Autoregulates Its Expression by Stabilization of p53 in a Phosphatase-Independent Manner
Cancer Res., January 15, 2006; 66(2): 736 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Y. Zhao, J. Liu, G. S. Sidhu, Y. Niu, Y. Liu, R. Wang, and D. Liao
Negative Regulation of p53 Functions by Daxx and the Involvement of MDM2
J. Biol. Chem., November 26, 2004; 279(48): 50566 - 50579.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Tomasini, A. A. Samir, A. Carrier, D. Isnardon, B. Cecchinelli, S. Soddu, B. Malissen, J.-C. Dagorn, J. L. Iovanna, and N. J. Dusetti
TP53INP1s and Homeodomain-interacting Protein Kinase-2 (HIPK2) Are Partners in Regulating p53 Activity
J. Biol. Chem., September 26, 2003; 278(39): 37722 - 37729.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. B. Davis, Y. Dong, and R. H. Weiss
Overexpression of p73 causes apoptosis in vascular smooth muscle cells
Am J Physiol Cell Physiol, January 1, 2003; 284(1): C16 - C23.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Wong, P.-X. Li, and H. J. Klamut
A Novel p53 Transcriptional Repressor Element (p53TRE) and the Asymmetrical Contribution of Two p53 Binding Sites Modulate the Response of the Placental Transforming Growth Factor-beta Promoter to p53
J. Biol. Chem., July 12, 2002; 277(29): 26699 - 26707.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Yan, H. Wang, and D. D. Boyd
ATF3 Represses 72-kDa Type IV Collagenase (MMP-2) Expression by Antagonizing p53-dependent trans-Activation of the Collagenase Promoter
J. Biol. Chem., March 22, 2002; 277(13): 10804 - 10812.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Mendoza-Alvarez and R. Alvarez-Gonzalez
Regulation of p53 Sequence-specific DNA-binding by Covalent Poly(ADP-ribosyl)ation
J. Biol. Chem., September 21, 2001; 276(39): 36425 - 36430.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Klein, E. Planker, T. Diercks, H. Kessler, K.-P. Kunkele, K. Lang, S. Hansen, and M. Schwaiger
NMR Spectroscopy Reveals the Solution Dimerization Interface of p53 Core Domains Bound to Their Consensus DNA
J. Biol. Chem., December 21, 2001; 276(52): 49020 - 49027.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.